Peptide safety profile Preclinical research on BPC-157 safety is relatively encouraging
A clinical study found that as the intake of iron supplements increased (categorized as low, moderate, and high iron dose groups with intakes of 2.99 and 3.6 mg/4,184 kJ), the odds ratio for developing UC increased, indicating an increased disease risk with higher iron intake [273]
As an early phase study, it was powered to the primary end points of ICP reduction with single and repeated dosing
Ces complments alimentaires peuvent notamment devenir de prcieux allis lorsque lorganisme doit faire face de multiples agressions extrieures
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Rohrmann S, Linseisen J, Allenspach M, von Eckardstein A, Muller D